Causes of Acute Hospitalization in Adolescence: Burden and Spectrum of HIV-Related Morbidity in a Country with an Early-Onset and Severe HIV Epidemic: A Prospective Survey
Background:
Survival to older childhood with untreated, vertically acquired HIV infection, which was previously considered extremely unusual, is increasingly well described. However, the overall impact on adolescent health in settings with high HIV seroprevalence has not previously been investigated.
Methods and Findings:
Adolescents (aged 10–18 y) systematically recruited from acute admissions to the two public hospitals in Harare, Zimbabwe, answered a questionnaire and underwent standard investigations including HIV testing, with consent. Pre-set case-definitions defined cause of admission and underlying chronic conditions. Participation was 94%. 139 (46%) of 301 participants were HIV-positive (median age of diagnosis 12 y: interquartile range [IQR] 11–14 y), median CD4 count = 151; IQR 57–328 cells/µl), but only four (1.3%) were herpes simplex virus-2 (HSV-2) positive. Age (median 13 y: IQR 11–16 y) and sex (57% male) did not differ by HIV status, but HIV-infected participants were significantly more likely to be stunted (z-score<−2: 52% versus 23%, p<0.001), have pubertal delay (15% versus 2%, p<0.001), and be maternal orphans or have an HIV-infected mother (73% versus 17%, p<0.001). 69% of HIV-positive and 19% of HIV-negative admissions were for infections, most commonly tuberculosis and pneumonia. 84 (28%) participants had underlying heart, lung, or other chronic diseases. Case fatality rates were significantly higher for HIV-related admissions (22% versus 7%, p<0.001), and significantly associated with advanced HIV, pubertal immaturity, and chronic conditions.
Conclusion:
HIV is the commonest cause of adolescent hospitalisation in Harare, mainly due to adult-spectrum opportunistic infections plus a high burden of chronic complications of paediatric HIV/AIDS. Low HSV-2 prevalence and high maternal orphanhood rates provide further evidence of long-term survival following mother-to-child transmission. Better recognition of this growing phenomenon is needed to promote earlier HIV diagnosis and care.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Causes of Acute Hospitalization in Adolescence: Burden and Spectrum of HIV-Related Morbidity in a Country with an Early-Onset and Severe HIV Epidemic: A Prospective Survey. PLoS Med 7(2): e32767. doi:10.1371/journal.pmed.1000178
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000178
Souhrn
Background:
Survival to older childhood with untreated, vertically acquired HIV infection, which was previously considered extremely unusual, is increasingly well described. However, the overall impact on adolescent health in settings with high HIV seroprevalence has not previously been investigated.
Methods and Findings:
Adolescents (aged 10–18 y) systematically recruited from acute admissions to the two public hospitals in Harare, Zimbabwe, answered a questionnaire and underwent standard investigations including HIV testing, with consent. Pre-set case-definitions defined cause of admission and underlying chronic conditions. Participation was 94%. 139 (46%) of 301 participants were HIV-positive (median age of diagnosis 12 y: interquartile range [IQR] 11–14 y), median CD4 count = 151; IQR 57–328 cells/µl), but only four (1.3%) were herpes simplex virus-2 (HSV-2) positive. Age (median 13 y: IQR 11–16 y) and sex (57% male) did not differ by HIV status, but HIV-infected participants were significantly more likely to be stunted (z-score<−2: 52% versus 23%, p<0.001), have pubertal delay (15% versus 2%, p<0.001), and be maternal orphans or have an HIV-infected mother (73% versus 17%, p<0.001). 69% of HIV-positive and 19% of HIV-negative admissions were for infections, most commonly tuberculosis and pneumonia. 84 (28%) participants had underlying heart, lung, or other chronic diseases. Case fatality rates were significantly higher for HIV-related admissions (22% versus 7%, p<0.001), and significantly associated with advanced HIV, pubertal immaturity, and chronic conditions.
Conclusion:
HIV is the commonest cause of adolescent hospitalisation in Harare, mainly due to adult-spectrum opportunistic infections plus a high burden of chronic complications of paediatric HIV/AIDS. Low HSV-2 prevalence and high maternal orphanhood rates provide further evidence of long-term survival following mother-to-child transmission. Better recognition of this growing phenomenon is needed to promote earlier HIV diagnosis and care.
: Please see later in the article for the Editors' Summary
Zdroje
1. SellsCW
BlumRW
1996 Morbidity and mortality among US adolescents: an overview of data and trends. Am J Public Health 86 513 519
2. CaflischM
AlvinP
2000 Management of adolescents in pediatric hospitals. A national survey. Arch Pediatr 7 732 737
3. RosenEU
1988 Adolescent health problems–can paediatricians in the RSA cope? S Afr Med J 73 337 339
4. ObasiAI
BaliraR
ToddJ
RossDA
ChangaluchaJ
2001 Prevalence of HIV and Chlamydia trachomatis infection in 15–19-year olds in rural Tanzania. Trop Med Int Health 6 517 525
5. AgyeiWK
EpemaEJ
LubegaM
1992 Contraception and prevalence of sexually transmitted diseases among adolescents and young adults in Uganda. Int J Epidemiol 21 981 988
6. StoverJ
WalkerN
GrasslyNC
MarstonM
2006 Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect 82 iii45 iii50
7. MarstonM
ZabaB
SalomonJA
BrahmbhattH
BagendaD
2005 Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr 38 219 227
8. WalkerAS
MulengaV
SinyinzaF
LishimpiK
NunnA
2006 Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr 42 637 645
9. FerrandRA
LuethyR
BwakuraF
MujuruH
MillerRF
2007 HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Clin Infect Dis 44 874 878
10. UNAIDS 2008 Report on the global HIV/AIDS epidemic Geneva UNAIDS
11. FerrandRA
CorbettEL
WoodR
HargroveJ
NdhlovuCE
2009 AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. Aids 23 2039 2046
12. ShahI
2005 Age related clinical manifestations of HIV infection in Indian children. J Trop Pediatr 51 300 303
13. BakakiP
KayitaJ
Moura MachadoJE
CoulterJB
TindyebwaD
2001 Epidemiologic and clinical features of HIV-infected and HIV-uninfected Ugandan children younger than 18 months. J Acquir Immune Defic Syndr 28 35 42
14. BobatR
CoovadiaH
MoodleyD
CoutsoudisA
1999 Mortality in a cohort of children born to HIV-1 infected women from Durban, South Africa. S Afr Med J 89 646 648
15. GrantAD
DjomandG
SmetsP
KadioA
CoulibalyM
1997 Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'Ivoire. AIDS 11 1357 1364
16. World Health Organization 2005 Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance- African Region Geneva World Health Organization
17. ArchibaldLK
McDonaldLC
AddisonRM
McKnightC
ByrneT
2000 Comparison of BACTEC MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. J Clin Microbiol 38 2994 2997
18. ColeTJ
1997 Growth monitoring with the British 1990 growth reference. Arch Dis Child 76 47 49
19. VictoraCG
HuttlySR
FuchsSC
OlintoMT
1997 The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 26 224 227
20. CorbettEL
ChurchyardGJ
CharalambosS
SambB
MoloiV
2002 Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 34 1251 1258
21. GrantAD
SidibeK
DomouaK
BonardD
Sylla-KokoF
1998 Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis 2 926 934
22. JeenaPM
CoovadiaHM
ThulaSA
BlytheD
BuckelsNJ
1998 Persistent and chronic lung disease in HIV-1 infected and uninfected African children. Aids 12 1185 1193
23. ArpadiSM
2000 Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 25 S37 S42
24. BuchaczK
RogolAD
LindseyJC
WilsonCM
HughesMD
2003 Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr 33 56 65
25. WeissHA
BuveA
RobinsonNJ
Van DyckE
KahindoM
2001 The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 15 S97 S108
26. GregsonS
NyamukapaCA
GarnettGP
MasonPR
ZhuwauT
2002 Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 359 1896 1903
27. LopmanBA
GarnettGP
MasonPR
GregsonS
2005 Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS Med 2 e37 doi:10.1371/journal.pmed.0020037
28. GomoE
RusakanikoS
MashangeW
MutswangaJ
ChandiwanaB
2005 Household survey of HIV-prevalence and behaviour in Chimanimani District, Zimbabwe Cape Town, South Africa Human Social Research Council
29. BrookesH
ShisanaO
RichterL
2004 The national household HIV prevalence and risk survey of South African children Cape Town Human Social Research Council
30. NewellML
CoovadiaH
Cortina-BorjaM
RollinsN
GaillardP
2004 Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364 1236 1243
31. SohCH
OleskeJM
BradyMT
SpectorSA
BorkowskyW
2003 Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 362 2045 2051
32. WalkerAS
DoerholtK
SharlandM
GibbDM
2004 Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV. Paediatric Study Aids 18 1915 1924
33. NewellML
PatelD
GoetghebuerT
ThorneC
2006 CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis 193 954 962
34. Bakeera-KitakaS
McKellarM
SniderC
KekitiinwaA
PiloyaT
2008 Antiretroviral therapy for HIV-1 infected adolescents in Uganda: assessing the impact on growth and sexual maturation. Pediatr Infect Dis J 3 97 104
35. KekitiinwaA
LeeKJ
WalkerAS
MagandaA
DoerholtK
2008 Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 49 384 392
36. Bikaako-KajuraW
LuyirikaE
PurcellDW
DowningJ
KaharuzaF
2006 Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 10 S85 S93
37. FerrandRA
LoweS
WhandeB
MunaiwaL
LanghaugL
2009 Survey of children accessing HIV services in a high HIV prevalence setting: time for HIV-infected adolescents to count? Bull World Health Organ In press
38. Ministry of Health and Child Welfare 2007 Zimbabwe national HIV and AIDS estimates 2007 Harare, Zimbabwe Ministry of Health and Child Welfare
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
- Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?
- Developing Global Maps of the Dominant Vectors of Human Malaria
- Guidance for Developers of Health Research Reporting Guidelines